| Name | Title | Contact Details |
|---|
HealthSTAR Communications, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Cano Health operates healthcare centers specializing in Senior Care and Primary Care for all ages. In addition to primary medical care, Cano Health has specialty programs in the fields of Venous Medicine, Arthritis, Allergy, and Weight Loss. OUR MISSION Our mission is to improve patient health by delivering superior primary care medical services, while forging a life-long bond with our members. OUR VISION Our vision is to become the national leader in primary care by improving the health, wellness, and quality of life of the communities we serve, while reducing health care costs.
Amway is the world`s No. 1 direct selling business, according to the Direct Selling News Global 100. Established in 1959, with sales of $8.6 billion, Amway operates in more than 100 countries and territories. We manufacture and distribute 450+ consumer products that support health and well-being. More than 19,000 employees worldwide support millions of Amway Business Owners who sell Amway products. Headquartered in Ada, Michigan, Amway is a center of health, skincare and home product innovation and top-selling, global brands. In addition, we are a company committed to providing employees with challenging career opportunities, a comprehensive total rewards package, profit sharing, tuition assistance, product discounts and an award-winning wellness program.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Women In Need is a Portland, ME-based company in the Healthcare, Pharmaceuticals, & Biotech sector.